Blue-chip companies Unilever, AstraZeneca and British American Tobacco today lead a busy session for end-of-year corporate earnings.
AstraZeneca boss Pascal Soriot reported a 25% rise in revenues to $44.3 billion (£36.6 billion) and said he expects to see another year of double-digit revenue growth in 2023.
